Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology

By N. Ashton, W. Brum, Guglielmo di Molfetta, A. Benedet, Burak Arslan, E. Jonaitis, Rebecca E Langhough, K. Cody, Rachael Wilson, C. Carlsson and 17 more. JAMA Neurology, 2024

702 citations recorded by the source corpus.

This cohort study examines data from 3 single-center observational cohorts to test the capabilities of a commercially available plasma phosphorylated tau 217 immunoassay to identify Alzheimer disease pathophysiology.

Subfields: Molecular Biology, Physiology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/b4bcdf665c0038cf07b0ea5703946b45dfbb4d36

Citations in the corpus

• Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup (2024, unknown): “69,74,76,77 Accuracy must be defined in the intended-use population.”